This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1963 Jan:12:60-1.

doi: 10.4269/ajtmh.1963.12.60.

Pyrvinium pamoate in the treatment of strongyloidiasis

PMID: 13998220
DOI: 10.4269/ajtmh.1963.12.60

Pyrvinium pamoate in the treatment of strongyloidiasis

E D WAGNER. Am J Trop Med Hyg. 1963 Jan.

. 1963 Jan:12:60-1.

doi: 10.4269/ajtmh.1963.12.60.

Author

PMID: 13998220
DOI: 10.4269/ajtmh.1963.12.60

No abstract available

PubMed Disclaimer

Similar articles

STRONGYLOIDIASIS TREATED WITH PYRVINIUM PAMOATE.
WANG CC, GALLI GA. WANG CC, et al. JAMA. 1965 Sep 6;193:847-8. doi: 10.1001/jama.1965.03090100093040. JAMA. 1965. PMID: 14330001 No abstract available.
[Effectiveness of pyrvinium pamoate in treating strongyloidiasis].
Tikhomirova EP, Prokhorov AF, Barinova KhG, Dotsenko VA, Lysakova LA. Tikhomirova EP, et al. Med Parazitol (Mosk). 1979 Sep-Oct;48(5):30-3. Med Parazitol (Mosk). 1979. PMID: 537582 Russian. No abstract available.
A case of strongyloidiasis treated with pyrvinium chloride.
METZL K. METZL K. Am J Trop Med Hyg. 1963 Mar;12:209-10. doi: 10.4269/ajtmh.1963.12.209. Am J Trop Med Hyg. 1963. PMID: 13935222 No abstract available.
The novel role of pyrvinium in cancer therapy.
Momtazi-Borojeni AA, Abdollahi E, Ghasemi F, Caraglia M, Sahebkar A. Momtazi-Borojeni AA, et al. J Cell Physiol. 2018 Apr;233(4):2871-2881. doi: 10.1002/jcp.26006. Epub 2017 Jun 20. J Cell Physiol. 2018. PMID: 28500633 Review.
Treatment of common parasitic infections of man encountered in the United States. I.
Most H. Most H. N Engl J Med. 1972 Sep 7;287(10):495-8. doi: 10.1056/NEJM197209072871006. N Engl J Med. 1972. PMID: 4560453 Review. No abstract available.

See all similar articles

Cited by

Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug.
Schultz CW, Nevler A. Schultz CW, et al. Biomedicines. 2022 Dec 14;10(12):3249. doi: 10.3390/biomedicines10123249. Biomedicines. 2022. PMID: 36552005 Free PMC article. Review.
Synergy between Pyrvinium Pamoate and Azoles against Exophiala dermatitidis.
Gao L, Sun Y, He C, Zeng T, Li M. Gao L, et al. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02361-17. doi: 10.1128/AAC.02361-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29437619 Free PMC article. No abstract available.
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.
Ponzini FM, Schultz CW, Leiby BE, Cannaday S, Yeo T, Posey J, Bowne WB, Yeo C, Brody JR, Lavu H, Nevler A. Ponzini FM, et al. BMJ Open. 2023 Oct 17;13(10):e073839. doi: 10.1136/bmjopen-2023-073839. BMJ Open. 2023. PMID: 37848297 Free PMC article.
Synergistic Effect of Pyrvinium Pamoate and Azoles Against Aspergillus fumigatus in vitro and in vivo.
Sun Y, Gao L, Zhang Y, Yang J, Zeng T. Sun Y, et al. Front Microbiol. 2020 Nov 3;11:579362. doi: 10.3389/fmicb.2020.579362. eCollection 2020. Front Microbiol. 2020. PMID: 33224118 Free PMC article.
In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assay.
Downey AS, Graczyk TK, Sullivan DJ. Downey AS, et al. J Antimicrob Chemother. 2009 Oct;64(4):751-4. doi: 10.1093/jac/dkp296. Epub 2009 Aug 18. J Antimicrob Chemother. 2009. PMID: 19689977 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Sheridan PubFactory